// App-Quantinova.ai

: Radiotherapy for adults with pituitary adenoma or craniopharyngioma is associated with increased risk of second brain tumour : A multi-centre study of 3,613 patients with long-term imaging surveillance

Researchers

Presenter

  • Ross Hamblin

Principal Investigators

  • Josephine Akpalu

  • Metaxia Tampourlou

  • Ioannis Spiliotis

  • Emilia Sbardella

  • Julie Lynch

  • Vani Shankaran

  • Akash Mavilakandy

  • Irene Gagliardi

  • Sara Meade

  • Claire Hobbs

  • Alison Cameron

  • Miles J Levy

  • John Ayuk

  • Ashley Grossman

  • Maria Rosaria Ambrosio

  • Maria Chiara Zatelli

  • Narendra Reddy

  • Karin Bradley

  • Robert Murray

  • Aparna Pal

  • Niki Karavitaki

Medical Centers

  • Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK

  • Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK

  • Department of Ophthalmology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust , Birmingham, United Kingdom

  • Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford University Hospital NHS Trust, Oxford, United Kingdom

  • Department of Endocrinology, Leeds Teaching Hospitals NHS Trust, St Jamess University Hospital, Leeds, UK

  • Department of Diabetes & Endocrinology, University Hospitals of Leicester NHS Trust, Leicester Royal Infirmary, Leicester, UK

  • Section of Endocrinology, Department of Medical Sciences, University of Ferrara, Ferrara, Italy

  • Department of Ophthalmology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust , Birmingham, United Kingdom

  • Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

  • Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom

  • Thoracic Surgery, Bristol Royal Infirmary, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom

Locations

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Oncology (ONC)

Disease

  • Pituitary adenomas

  • Craniopharyngioma

  • Cerebral metastases

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multicenteric

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A